HomeIndicesNIFTY HEALTHCARE

N

Nifty Healthcare

NIFTY HEALTHCARE Share Price

NSE

14,468.70

-411.55 (-2.77%)profit
1D

Last Updated on 01 Aug 2025 at 19:35

TradingView Logo

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

NIFTY HEALTHCARE Performance

Markets Today

High

14,847.90

Low

14,447.50

Open at

14,845.65

Prev Close

14,880.25

Volumes

0

Avg Price

0.00

Lower Circuit

0.00

Upper Circuit

0.00

Last Traded Details

Quantity

0

Time

19:35:58

Price Movement

14,447.50
14,468.70
14,847.90
Loss 0.15%down side
up side2.55% profit

Historical Performance

3 M High

15,079.85

3 M Low

13,445.85

1 Yr High

15,108.80

1 Yr Low

12,561.70

3 Yr High

15,108.80

3 Yr Low

8,920.90

5 Yr High

15,108.80

5 Yr Low

8,920.90

1-Year Performance

12,561.70
14,468.70
15,108.80
loss0.15%down side
up side2.55% profit

Market Insights

Positive Stocks

1

Negative Stocks

18

Neutral Stocks

1


NIFTY HEALTHCARE Latest News

Cipla Denies Awareness of Trump Letters Report Amid Pharma Stock Decline

sentiment_img

Cipla responded to reports suggesting pharmaceutical stocks fell due to Trump sending letters to 17 global drug companies requesting lower prices. The company denied having awareness of this news and stated there is no undisclosed information behind the stock price changes.

15 hours ago

Apollo Hospitals Subsidiary Directed to Pay INR 4.96 Crore for Foreign Exchange Rule Violation

sentiment_img

Apollo Hospitals Enterprise Limited disclosed that its subsidiary Apollo Healthco Limited has been directed by the Reserve Bank of India to deposit INR 4,95,50,000 for compounding a contravention of foreign exchange management rules. The RBI order dated July 31, 2025 relates to violation of Rule 4 read with Rule 2(k) of Foreign Exchange Management (Non-debt Instruments) Rules, 2019. Apollo Healthco had filed a compounding application with RBI regarding this contravention. The company stated there is no impact on financial, operational or other activities due to this order, and no further claims, penalties or proceedings are pending. The company remains in compliance with all applicable regulations and confirmed this development does not impact operations, financial health or future outlook.

16 hours ago

Granules India Receives One Procedural Observation from US FDA Pre-Approval Inspection

sentiment_img

Granules India announced that the US FDA has completed a pre-approval inspection at one of the company's facilities. The inspection resulted in one procedural observation being issued to the company.

17 hours ago

Abbott India Pays Rs. 2 Lakh Penalty to RBI for Exceeding Foreign Investment Limits

sentiment_img

Abbott India Limited received a Compounding Order from the Reserve Bank of India's Foreign Exchange Department on July 31, 2025, requiring the company to pay Rs. 2,00,000 as penalty. The violation involved foreign investment in the company exceeding 75% due to secondary market transactions on stock exchanges without obtaining prior government approval, contravening foreign exchange laws. The company will deposit the compounding amount as directed. Once the compounding process is closed, Abbott India will be able to receive investment from foreign institutional investors up to the prescribed limit.

22 hours ago

Sun Pharma Shares Drop 4% After Trump Demands Drug Price Cuts from Major Pharmaceutical Companies

sentiment_img

Sun Pharma shares declined 4% after initially falling 6%, leading losses in the Nifty Pharma index following US President Donald Trump's letters to 17 major pharmaceutical companies demanding lower drug prices. Trump's letter required companies to charge the US similar rates to other countries for new medicines and lower Medicaid costs for existing drugs, with 60 days given for voluntary compliance. Sun Pharma derives around 20% of its revenues from innovative drugs sold in the US and had not received such communication as of their last quarterly conference call. The Trump administration is seeking most favoured nation treatment for Medicaid pricing to match rates charged in other wealthy developed nations. Other pharmaceutical stocks also declined, with Aurobindo Pharma, Gland and Granules India falling 2-3%. Most Indian generic companies face limited impact as they don't sell branded generics or innovator drugs.

23 hours ago

View More


NIFTY HEALTHCARE Technicals

Moving Averages

PeriodSimpleSignal
5-SMA14,859.44Bearish
10-SMA14,770.12Bearish
20-SMA14,700.20Bearish
50-SMA14,381.11Bullish
100-SMA14,041.59Bullish
200-SMA14,081.46Bullish

Technical Indicators

IndicatorValueAction
RSI(14)44.73Neutral
ATR(14)180.31Volatile
STOCH(9,6)72.22Neutral
STOCH RSI(14)47.28Neutral
MACD(12,26)-17.57Bearish
ADX(14)21.76Weak Trend

Summary of Technical Indicators for NIFTY HEALTHCARE


NIFTY HEALTHCARE Companies

NIFTY HEALTHCARE Gainers
LTP
Change%
Weightage
Market Cap (Cr.)
PE Ratio
52W High
52W Low

F

Fortis Healthcare

859.25

0.21%3.294%₹ 64,733.9076.76859.95480.55

M

Max Healthcare Institute

1,246.00

0.00%6.164%₹ 1,21,129.50106.861,314.30836.60

NIFTY HEALTHCARE Sector Weightage

View All Sector arrow
Sectors
Companies
Weightage
Market Cap (Cr.)

Healthcare

1785.05%16,71,302.20

Healthcare Services

314.95%2,93,673.10

NIFTY HEALTHCARE Share Price History

Close Price

Volume

NIFTY HEALTHCARE share price in last 10 trading sessions

DayOpenCloseChange%Day HighDay LowVolume
01 Aug 202514,845.6514,468.70
-2.54% Loss
14,847.9014,447.503,19,57,083
31 Jul 202514,839.3514,880.25
0.28% profit
15,004.0014,828.253,02,06,788
30 Jul 202515,063.7515,040.45
-0.15% Loss
15,079.8514,995.702,78,32,951
29 Jul 202514,844.7515,047.70
1.37% profit
15,068.3014,837.252,89,46,636
28 Jul 202514,859.4514,860.10
0.00% profit
14,964.7514,799.454,11,01,966
25 Jul 202514,724.0014,846.30
0.83% profit
14,859.4514,688.403,02,60,512
24 Jul 202514,679.0014,744.50
0.45% profit
14,798.0014,677.652,65,78,448
23 Jul 202514,530.3014,649.95
0.82% profit
14,664.6014,526.252,20,52,556
22 Jul 202514,651.7014,528.50
-0.84% Loss
14,673.6514,497.702,12,69,699
21 Jul 202514,651.9014,634.75
-0.12% Loss
14,689.3014,577.051,76,07,799

NIFTY HEALTHCARE Historical Returns

Year Jan Feb MarAprMayJun JulAugSepOctNovDecAnnually

2025

-7.78%-8.00%7.85%2.72%-1.16%4.13%2.88%-2.77%NANANANA-3.23%

2024

7.37%4.63%0.91%-0.70%-1.50%6.62%9.34%5.50%1.69%-2.20%-2.09%5.84%40.55%

2023

0.00%4.91%2.54%-4.77%11.17%3.39%NANANANANANA0.00%

NIFTY HEALTHCARE Investment Returns

1 Week

1 Month

3 Month

6 Month

9 Month

SIP Logo

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.


NIFTY HEALTHCARE Comparison
Broad Based Indices
Sectoral Indices
Name
LTP
Change
Change %arrow
1M Returns
3M Returns
6M Returns
1Y Returns
3Y Returns
5Y Returns
Nifty Healthcare

N

Nifty Healthcare

₹ 14,468.70

-411.55-2.77%-0.18%3.58%5.03%4.94%59.96%59.96%
Sensex

S

Sensex

₹ 80,599.91

-585.67-0.72%-3.70%0.12%3.99%-1.55%38.69%118.19%
Nifty 50

N

Nifty 50

₹ 24,565.35

-203.00-0.82%-3.82%0.90%4.61%-1.78%41.67%125.54%
BSE 100

B

BSE 100

₹ 25,730.72

-231.06-0.89%-3.92%1.34%4.41%-2.75%45.20%134.10%
NIFTY 100

N

NIFTY 100

₹ 25,149.60

-230.90-0.91%-3.85%1.21%4.54%-3.49%42.91%127.47%
NIFTY 500

N

NIFTY 500

₹ 22,673.65

-241.30-1.05%-3.99%3.03%5.06%-3.54%52.72%153.85%
BSE 500

B

BSE 500

₹ 35,598.07

-383.67-1.07%-3.90%2.81%4.84%-4.13%50.52%151.00%
Sensex Next 50 Index

S

Sensex Next 50 Index

₹ 81,866.78

-899.39-1.09%-4.30%3.19%4.96%-4.28%66.97%66.73%
NIFTY Midcap 150

N

NIFTY Midcap 150

₹ 21,088.65

-272.65-1.28%-3.93%6.84%6.65%-2.85%85.57%259.24%
Nifty Next 50

N

Nifty Next 50

₹ 66,192.80

-903.35-1.35%-3.97%2.74%4.24%-10.91%59.50%147.67%
Nifty Midcap Select

N

Nifty Midcap Select

₹ 12,668.25

-198.85-1.55%-5.57%5.77%6.77%-1.46%76.11%63.73%
NIFTY Smallcap 250

N

NIFTY Smallcap 250

₹ 16,863.25

-281.00-1.64%-5.06%9.83%5.69%-5.40%88.73%65.03%

NIFTY HEALTHCARE Performers
Outperformers
Underperformers
Name
LTP
Change%arrow
High
Low
Nifty Healthcare

N

Nifty Healthcare

₹ 14,468.70

-2.77%₹ 14,847.90₹ 14,447.50
Fortis Healthcare

F

Fortis Healthcare

₹ 859.25

0.21%₹ 867.35₹ 849.75
Max Healthcare Institute

M

Max Healthcare Institute

₹ 1,246.00

-₹ 1,258.20₹ 1,239.00
Mankind Pharma

M

Mankind Pharma

₹ 2,566.30

-0.04%₹ 2,652.70₹ 2,558.90
Syngene International

S

Syngene International

₹ 703.25

-1.51%₹ 714.35₹ 700.15
IPCA Laboratories

I

IPCA Laboratories

₹ 1,450.20

-1.61%₹ 1,489.40₹ 1,439.30
Torrent Pharmaceuticals

T

Torrent Pharmaceuticals

₹ 3,678.20

-1.70%₹ 3,740.90₹ 3,642.00
Apollo Hospitals

A

Apollo Hospitals

₹ 7,351.50

-1.95%₹ 7,538.00₹ 7,331.50
Biocon

B

Biocon

₹ 383.10

-2.12%₹ 392.85₹ 381.80
Zydus Life Science

Z

Zydus Life Science

₹ 949.05

-2.14%₹ 970.75₹ 946.35
Abbott

A

Abbott

₹ 33,595.00

-2.35%₹ 34,815.00₹ 33,205.00

Corporate Action of NIFTY HEALTHCARE Stocks

4th Aug 2025, Monday
Aurobindo Pharma

A

Aurobindo Pharma

Event

QUARTERLY RESULT ANNOUNCEMENTStock Result

LTP (1D Chg%)

₹ 1,101.40 (-5.26%)

Details

Q1 FY 25-26 Results
info
5th Aug 2025, Tuesday
Lupin

L

Lupin

Event

QUARTERLY RESULT ANNOUNCEMENTStock Result

LTP (1D Chg%)

₹ 1,930.85 (-3.20%)

Details

Q1 FY 25-26 Results
info
6th Aug 2025, Wednesday
Divis Laboratories

D

Divis Laboratories

Event

QUARTERLY RESULT ANNOUNCEMENTStock Result

LTP (1D Chg%)

₹ 6,618.65 (-3.55%)

Details

Q1 FY 25-26 Results
info
7th Aug 2025, Thursday
Biocon

B

Biocon

Event

QUARTERLY RESULT ANNOUNCEMENTStock Result

LTP (1D Chg%)

₹ 372.05 (-2.12%)

Details

Q1 FY 25-26 Results
info
8th Aug 2025, Friday
Alkem Laboratories

A

Alkem Laboratories

Event

DIVIDENDDividend

LTP (1D Chg%)

₹ 5,265.65 (-2.63%)

Details

Final Dividend of ₹8 Per Share
11th Aug 2025, Monday
IPCA Laboratories

I

IPCA Laboratories

Event

QUARTERLY RESULT ANNOUNCEMENTStock Result

LTP (1D Chg%)

₹ 1,462.05 (-1.61%)

Details

Q1 FY 25-26 Results
info
12th Aug 2025, Tuesday
Apollo Hospitals

A

Apollo Hospitals

Event

QUARTERLY RESULT ANNOUNCEMENTStock Result

LTP (1D Chg%)

₹ 7,352.50 (-1.95%)

Details

Q1 FY 25-26 Results
info
Granules

G

Granules

Event

QUARTERLY RESULT ANNOUNCEMENTStock Result

LTP (1D Chg%)

₹ 468.90 (-4.87%)

Details

Q1 FY 25-26 Results
info

The above dates are ex-dates.

View All Stock Events arrow

NIFTY HEALTHCARE ETF

Name
LTP (NAV)
Change%
1 Yr Returns
3 Yr Returnsarrow
5 Yr Returns
Expense Ratio
Asset (in Cr.)
Aditya Birla Nifty Healthcare ETF

Aditya Birla Nifty Healthcare ETF

₹ 14.88

-2.49%8.73%23.80%0.00%0.19%₹ 36.19
ICICI Pru Nifty Healthcare ETF

ICICI Pru Nifty Healthcare ETF

₹ 148.05

-2.61%8.82%23.62%0.00%0.15%₹ 143.37
Axis Nifty Healthcare ETF

Axis Nifty Healthcare ETF

₹ 147.26

-2.68%8.61%23.38%0.00%0.34%₹ 21.44
DSP Nifty Healthcare ETF

DSP Nifty Healthcare ETF

₹ 145.96

-2.68%8.76%0.00%0.00%0.2%₹ 10.38



Open IPOs

View All arrow
No Data

There are no Open IPOs at the moment.


FAQs

There are 20 companies in Nifty Healthcare as on 01 Aug 2025 at 19:35.
The current price of Nifty Healthcare is ₹14,468.70 as on 01 Aug 2025 at 19:35.
The past returns of Nifty Healthcare as on 01 Aug 2025 at 19:35 are -
  • Past 1 year: 4.94%
  • Past 3 years: 59.96%
  • Past 5 years: 59.96%
The cumulative market capitalization of all the companies listed in Nifty Healthcare stands at ₹ NaN Cr. as on 01 Aug 2025 at 19:35.
No, you cannot buy Nifty Healthcare directly. However, you can trade futures and options of 5 NSE Indices (NIFTY, BANKNIFTY, FINNIFTY, MIDCPNIFTY and NIFTY NEXT 50) and 2 BSE Indices (BSE Sensex and BSE Bankex) at the moment.
Yes, you can individually purchase the stocks of Nifty Healthcare on Dhan using Dhan trading app or web trading platform.
You can purchase the stocks of Nifty Healthcare using Dhan's demat account. Follow the below steps if you are new to Dhan -
  1. Download the Dhan App to open a Open Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for the stock you want to buy
  5. Tap on “Buy”.
Candle bars with Screen
Invest in
NIFTY HEALTHCARE
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's #MadeForTrade

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2025 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors